Glenmark Pharmaceuticals U.S. > News

News

Press Releases

Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.

Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Tablets USP, 10 mEq & 20 mEq

July 27, 2016

Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Ointment USP, 0.5%

July 25, 2016

Glenmark receives ANDA approval for Rosuvastatin Calcium Tablets

July 21, 2016

Glenmark Pharmaceuticals receives ANDA approval for Rosuvastatin Calcium Tablets

July 20, 2016

Glenmark receives tentative ANDA approval for Olmesartan Medoxomil Tablets

June 28, 2016

News

Search Result :-

Is an investigational new drug that has not been approved for commercial distribution in the United States.

July 27, 2016
Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Tablets USP, 10 mEq & 20 mEq

July 25, 2016
Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Ointment USP, 0.5%

July 21, 2016
Glenmark receives ANDA approval for Rosuvastatin Calcium Tablets

July 20, 2016
Glenmark Pharmaceuticals receives ANDA approval for Rosuvastatin Calcium Tablets

June 28, 2016
Glenmark receives tentative ANDA approval for Olmesartan Medoxomil Tablets

US Media Contact

For media inquiries only, please contact Corporate Communications.
uscomms@glenmarkpharma.com

Investor Relations

For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.

POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES 750mg RECALL REIMBURSEMENT POLICY

Over-the-counter (OTC)

ACCESSIBLE PRODUCTS

Who We Are

Injectables

OUR GROWING LINE